首页> 外文OA文献 >Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

【2h】

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

机译：vorinostat，组蛋白脱乙酰酶抑制剂的I阶段I和药代动力学研究，与Carboplatin和Parlitaxel联合治疗晚期固体恶性肿瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Suresh S. Ramalingam; Robert A. Parise; Ramesh K. Ramananthan; Theodore F. Lagattuta; Lori A. Musguire; Ronald G. Stoller; Douglas M. Potter; Athanassios E. Argiris; James A. Zwiebel; Merrill J. Egorin; Chandra P. Belani;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and|[sol]|or paclitaxel in patients with solid tumours [J] . U Lassen, L R Molife, M Sorensen, British Journal of Cancer . 2010,第1期

机译：组蛋白脱乙酰基酶抑制剂贝利司他与卡铂和| [sol] |或紫杉醇联合给药对实体瘤患者的安全性和药代动力学的I期研究
2. A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers [J] . Ma Wen Wee, Zhu Mojun, Lam Elaine T., Cancer chemotherapy and pharmacology. . 2021,第6期

机译：紫杉醇注射浓缩液对纳米分散体（PICN）的一部分药代动力学和安全性研究，并与先进固体恶性肿瘤和胆道癌患者的卡铂组合
3. Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study. [J] . Leong S, Cohen RB, Gustafson DL Journal of Clinical Oncology . 2009,第26期

机译：Mapatumumab，一种靶向TRAIL-R1的抗体，与紫杉醇和卡铂联合用于晚期实体恶性肿瘤患者：I期和药代动力学研究的结果。
4. Synthesis, Evaluation and Molecular Modeling Study of L-2-amino-7/8-Bromoalkanoic Acid Derivatives as Histone Deacetylase Inhibitors [C] . Dawei Huang, Xiaohui Li, Zhilong Xiu, Chinese international peptide symposium . 2011

机译：L-2-氨基-7 / 8-溴烷酸衍生物作为组蛋白脱乙酰酶抑制剂的合成，评价和分子建模研究
5. The Synthetic Oleanane Triterpenoids and the Histone Deacetylase Inhibitor Vorinostat Cooperate to Delay Tumor Development in a Transgenic Model of Estrogen Receptor -- Negative Breast Cancer. [D] . Tran, Kim M. 2012

机译：合成的齐墩果烷三萜类化合物和组蛋白脱乙酰基酶抑制剂伏立诺他合用以延迟雌激素受体-阴性乳腺癌转基因模型中的肿瘤发展。
6. A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours [O] . U Lassen, L R Molife, M Sorensen, 2010

机译：组蛋白脱乙酰基酶抑制剂贝利司他与卡铂和/或紫杉醇联用对实体瘤患者的安全性和药代动力学的I期研究
7. A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours [O] . Lassen, U, Molife, L R, Sorensen, M, 2010

机译：组蛋白脱乙酰基酶抑制剂贝利司他与卡铂和/或紫杉醇联用对实体瘤患者的安全性和药代动力学的I期研究
8. Targeting MTA1/HIF-1alpha Signaling by Pterostilbene in Combination with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression (Open Access). [R] . Butt, N. A., Kumar, A., Dhar, S., 2017

机译：通过紫檀芪与组蛋白去乙酰化酶抑制剂组合靶向mTa1 / HIF-1α信号减弱前列腺癌进展（开放存取）。

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅